|
⚲
|
| Keyboard |
| Lamond Pierre
✚
|
|
|---|---|
| CIK # | 0001190683 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001190683] | |
| 4 | [0001190683] | |
| SC 13G | [0001190683] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Lamond Pierre | Cortexyme Inc | [2019-09-30] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Two | |
| Lamond Pierre | |
| Markforged Holding Corp | |
| Lamond Christine | |
| Quince Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quince Therapeutics Inc CRTX
Common Stock
|
2019-05-13 | Conversion | 962,510 | ||
|
Quince Therapeutics Inc CRTX
Common Stock
|
2019-05-13 | Conversion | 962,510 | ||
|
Quince Therapeutics Inc CRTX
Common Stock
|
2019-05-13 | Conversion | 961,510 | ||
|
Quince Therapeutics Inc CRTX
Series A Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 500,483 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Series A Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 500,482 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Series A Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 961,510 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 462,027 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 462,028 | $0.00 |